EZMEMS and the EIC Accelerator: A Sensor Chip, No Sales Announced

EZMEMS, based in Caesarea, Israel, builds its sensors on plastic chips. Its chip measures several properties of a liquid at once, so that disposable products such as infusion lines, plastic bags and bioreactors can report on what flows through them. Its EIC project called the product a "Smart Disposable multisensor" that turns simple medical or pharma products into "Smart products".

The European Innovation Council granted €2,500,000 towards DETERMINATION, a €3.7 million project from November 2022 to October 2024, aimed at mass production of multisensor-based medical devices with wireless connectivity. The final report describes a polymeric chip measuring "pressure, flow, temperature, turbidity, conductivity, and pH", a cloud data system, bench validation and field trials "underway". Since then, EZMEMS has not announced a customer, a sale, a production contract or a funding round, and its 2026 descriptions lead with industrial water as well as pharma.

Where EZMEMS Stands Now

In January 2026 the Israeli technology directory Isra-Tech described EZMEMS as applying its platform to "pharma and biotech processing and industrial water systems", with dissolved oxygen added to the parameters measured, and working with strategic partners in Germany on production, digitisation and product integration. The profile names no partner or customer. An earlier Isra-Tech profile, from August 2023, listed food, agriculture and water systems. A conference profile of its CEO mentions "sensor-as-a-service" and "scalable production models".

The Technology: Many Sensors, One Plastic Chip

Instead of packaging a separate sensor for each property, EZMEMS integrates several at chip level on a polymer substrate. The EIC report compared its chip with six standard industrial sensors costing about €20,000 each, using test apparatus that simulated process conditions. It does not publish the results of that comparison or the chip's price.

What the EIC Project Promised, and What CORDIS Shows

The project promised to "enable mass production" of smart medical and pharma devices. The report shows the chip, an IoT system from data capture to cloud visualisation, and field trials that had started but not finished. It reports no production line, no device integrated into a customer's product and no regulatory step. CORDIS still lists the project as signed, not closed.

1. Six-parameter chipDeliveredPer final report.
2. IoT data systemDeliveredAcquisition to cloud.
3. Field validationUnder wayNo results published.
4. Mass productionNot shownNo customer named.

The Money

EZMEMS is a private Israeli company and publishes no accounts. The EIC's blended finance award could include equity, but no EIC Fund investment in EZMEMS has been announced, and we found no other disclosed funding round.

What Cannot Be Checked

Why Europe Should Care

The EIC funded the development of a sensor platform that could make disposable medical and pharma products measurable. What came out is a working chip with no public customer, and the company's own descriptions have widened from medical devices to water, food and agriculture.

The Verdict

EZMEMS and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.